{
     "PMID": "11140673",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20010125",
     "LR": "20171116",
     "IS": "0028-0836 (Print) 0028-0836 (Linking)",
     "VI": "408",
     "IP": "6815",
     "DP": "2000 Dec 21-28",
     "TI": "Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms.",
     "PG": "936-43",
     "AB": "Stargazer, an ataxic and epileptic mutant mouse, lacks functional AMPA (alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate) receptors on cerebellar granule cells. Stargazin, the mutated protein, interacts with both AMPA receptor subunits and synaptic PDZ proteins, such as PSD-95. The interaction of stargazin with AMPA receptor subunits is essential for delivering functional receptors to the surface membrane of granule cells, whereas its binding with PSD-95 and related PDZ proteins through a carboxy-terminal PDZ-binding domain is required for targeting the AMPA receptor to synapses. Expression of a mutant stargazin lacking the PDZ-binding domain in hippocampal pyramidal cells disrupts synaptic AMPA receptors, indicating that stargazin-like mechanisms for targeting AMPA receptors may be widespread in the central nervous system.",
     "FAU": [
          "Chen, L",
          "Chetkovich, D M",
          "Petralia, R S",
          "Sweeney, N T",
          "Kawasaki, Y",
          "Wenthold, R J",
          "Bredt, D S",
          "Nicoll, R A"
     ],
     "AU": [
          "Chen L",
          "Chetkovich DM",
          "Petralia RS",
          "Sweeney NT",
          "Kawasaki Y",
          "Wenthold RJ",
          "Bredt DS",
          "Nicoll RA"
     ],
     "AD": "Department of Cellular and Molecular Pharmacology, University of California, San Francisco 94143, USA.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "England",
     "TA": "Nature",
     "JT": "Nature",
     "JID": "0410462",
     "RN": [
          "0 (CACNG2 protein, human)",
          "0 (Cacng2 protein, mouse)",
          "0 (Calcium Channels)",
          "0 (Disks Large Homolog 4 Protein)",
          "0 (Dlg4 protein, mouse)",
          "0 (Intracellular Signaling Peptides and Proteins)",
          "0 (Membrane Proteins)",
          "0 (Nerve Tissue Proteins)",
          "0 (Receptors, AMPA)",
          "0 (postsynaptic density proteins)",
          "3KX376GY7L (Glutamic Acid)",
          "EC 2.7.4.8 (Guanylate Kinases)",
          "SY7Q814VUP (Calcium)"
     ],
     "SB": "IM",
     "MH": [
          "Action Potentials",
          "Animals",
          "COS Cells",
          "Calcium/metabolism",
          "Calcium Channels/*genetics/physiology",
          "Cerebellum/metabolism",
          "Disks Large Homolog 4 Protein",
          "Down-Regulation",
          "Excitatory Postsynaptic Potentials",
          "Glutamic Acid/metabolism",
          "Guanylate Kinases",
          "Hippocampus/cytology/metabolism",
          "Humans",
          "Intracellular Signaling Peptides and Proteins",
          "Membrane Proteins",
          "Mice",
          "Mice, Mutant Strains",
          "Nerve Tissue Proteins/metabolism",
          "Neurons/metabolism",
          "Protein Transport",
          "Receptors, AMPA/*metabolism",
          "Synapses/*metabolism",
          "Synaptic Membranes/metabolism"
     ],
     "EDAT": "2001/01/05 11:00",
     "MHDA": "2001/02/28 10:01",
     "CRDT": [
          "2001/01/05 11:00"
     ],
     "PHST": [
          "2001/01/05 11:00 [pubmed]",
          "2001/02/28 10:01 [medline]",
          "2001/01/05 11:00 [entrez]"
     ],
     "AID": [
          "10.1038/35050030 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Nature. 2000 Dec 21-28;408(6815):936-43. doi: 10.1038/35050030.",
     "term": "hippocampus"
}